PlantEXT Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 2

PlantEXT General Information

Description

Developer of pharmaceutical-grade cannabis-based formulations designed for the treatment of inflammation-related medical conditions. The company employs proprietary technology to develop targeted cannabinoid and terpene combinations, supported by pre-clinical and clinical research, enabling healthcare providers to offer patients science-backed alternatives for managing conditions such as inflammatory bowel disease, dermatological issues, and pain.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2300 Yonge Street
  • Suite 1709
  • Toronto, Ontario M4P 1E4
  • Canada
+1 (416)
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 2300 Yonge Street
  • Suite 1709
  • Toronto, Ontario M4P 1E4
  • Canada
+1 (416)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PlantEXT Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private Completed Generating Revenue
3. Reverse Merger 01-Jul-2019 Cancelled Generating Revenue
2. Seed Round 01-Apr-2019 $1.2M $5.6M Completed Generating Revenue
1. Seed Round 01-Apr-2018 $4.4M $4.4M Completed Startup
To view PlantEXT’s complete valuation and funding history, request access »

PlantEXT Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PlantEXT Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
McGovern Capital Venture Capital Minority
Plant-Based Investment PE/Buyout Minority
To view PlantEXT’s complete investors history, request access »

PlantEXT Investments (1)

PlantEXT’s most recent deal was a Joint Venture with PlantEXT /Family Secret JV. The deal was made on 29-Apr-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
PlantEXT /Family Secret JV 29-Apr-2019 Joint Venture Other Pharmaceuticals and Biotechnology
To view PlantEXT’s complete investments history, request access »

PlantEXT FAQs

  • When was PlantEXT founded?

    PlantEXT was founded in 2015.

  • Where is PlantEXT headquartered?

    PlantEXT is headquartered in Toronto, Canada.

  • What is the size of PlantEXT?

    PlantEXT has 7 total employees.

  • What industry is PlantEXT in?

    PlantEXT’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is PlantEXT a private or public company?

    PlantEXT is a Private company.

  • What is PlantEXT’s current revenue?

    The current revenue for PlantEXT is .

  • How much funding has PlantEXT raised over time?

    PlantEXT has raised $5.6M.

  • Who are PlantEXT’s investors?

    McGovern Capital and Plant-Based Investment have invested in PlantEXT.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process